MCL1 and neoplasm: Studies have shown that increased levels of Mcl-1 in tumor cells is correlated with high levels of cell survival and development of resistance to diverse chemotherapeutic agents including ABT-737 (Thallinger et al., 2003; Sieghart et al., 2006; Keuling et al., 2009; Quinn et al., 2011).